ArticleBioMed research international2026
SNCA Overexpression Induces Apoptosis in Non-Small Cell Lung Cancer via Caspase-Dependent Signaling Pathways.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SNCA Overexpression Induces Apoptosis in Non-Small Cell Lung Cancer via Caspase-Dependent Signaling Pathways.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The alpha-synuclein (SNCA) gene is a Parkinson's disease (PD)-associated gene that is found to be downregulated in non-small cell lung cancer (NSCLC). Aberrant SNCA expression exerts neurotoxicity in PD by disrupting mitochondrial function, promoting protein aggregation or oxidative stress, ultimately leading to neuronal cell death. Numerous studies have hypothesized that SNCA is a tumor suppressor gene, but the underlying mechanism remains elusive. In this study, the SNCA gene is delivered to NSCLC cells via transfection of a plasmid vector with carbonate apatite (CA) nanoparticles as the delivery vehicle. Biochemical assays including cytotoxicity assay, oxidative stress assay, flow cytometry, and caspase activity assay were performed to assess the effects of SNCA overexpression in NSCLC cells. SNCA-overexpressed NSCLC cells were established using the optimized CA/plasmid complexes. SNCA overexpression promoted oxidative stress-induced cell death and apoptosis in both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) cells. Additionally, SNCA overexpression activated distinct caspases' activities in LUAD and LUSC. Besides, this study reveals that LUSC was more susceptible to the anticancer effects of SNCA overexpression than LUAD. As a result, SNCA overexpression promoted apoptosis under oxidative stress in NSCLC cells via distinct caspases' activations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.